Muscle-invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Muscle-invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-21Clinical Trial Update: Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer [NA]
A clinical trial evaluating daily online adaptive short-course radiation therapy with concurrent chemotherapy for muscle-invasive bladder ca…
-
CLINICAL_TRIALS withdrawal · 2025-10-21Clinical Trial Update: Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial [Phase 2]
The NERA trial, a Phase 2 study of erdafitinib with or without atezolizumab in localized bladder cancer patients ineligible for cisplatin ch…
-
CLINICAL_TRIALS withdrawal · 2024-09-25Clinical Trial Update: Clinical Performance Evaluation of the C2i Test
The clinical trial NCT05860543 evaluating the C2i Test for muscle-invasive bladder cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-17Clinical Trial Update: Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery [NA]
Clinical trial evaluating Gemcitabine hydrochloride, Cisplatin, and AGS-003-BLD for muscle-invasive bladder cancer undergoing surgery has be…
-
CLINICAL_TRIALS withdrawal · 2017-03-07Clinical Trial Update: Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder [Phase 1]
A Phase 1 trial evaluating intratumoral REOLYSIN in combination with gemcitabine and cisplatin as neoadjuvant therapy for muscle-invasive bl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.